News
September 12, 2022
Medvasc ab has appointed a new ceo – and strengthened the board with a high-profile life science executive
As the next step in MedVasc’s journey towards commercialization of the medical device Solutio™ in the US and European markets, the company has appointed Cathrin Johansson as new CEO and Eric Wahlberg as new Chair of the Board. Read more here!…
July 5, 2021
EIT Health Catapult Competition
We have been selected as a semifinalist in the EIT Health Catapult competition. Discover more about innovative projects for the healthcare industry. Don’t miss out on the semifinals event on 1-3 December 2021! Read more: https://eithealth.eventscase.com/EN/catapult_semifinals2021…
April 2, 2020
Promising results from first clinical study
Medvasc has conducted the first clinical study with the Solutio, the results are positive and we hope to proceed with more tests to verify the results within short. Read more here…
December 19, 2019
Medvasc raises SEK 3m
Through a directed new share issue Medvasc receives SEK 3M with the purpose of conducting the first clinical study. in conjunction with the financing round Mats Nilsson from MAQS takes the position as Chairman and the entrepreneur Magnus Olsson also becomes a member of the Board. Read more here…
April 2, 2019
Featured in LSX list of top 50 nordic startups
LSX Nordic Congress – a life science investment event taking place at Nasdaq’s Stockholm offices on August 28-29 (2019). An event with 200-250 stakeholders such as investors or CEO´s. Before the event, LSX put together a list with the top 50 Nordic startups – which all are invited. Among…
For press inquiries, please send an email
Subscribe to our newsletter
For more information on how we process your personal data please see our Privacy Notice
